Research theme for competitive and other funds (14):
2020 - 2023 Exploratory study to find predictive genomic biomarkers using liquid biopsy in multiple myeloma
2020 - 2023 エンハンサープロファイリングによる造血器腫瘍の分子病態理解と治療法の開発
2016 - 2020 Identification of blood biomarkers predicting clinical efficacy of molecular targeting agents in multiple myeloma
2008 - 2010 Identification of effective supportive care for cancer patients undergoing chemotherapy on evidence-based QOL assessment
2005 - 2009 The scientific clinical study of antibody therapy
2007 - 2008 Analysis of clinical feature and molecular pathogenesis of multiple myeloma with the gain of chromosome arm 1q21
2005 - 2006 Molecular analysis of autonomous activating mutation of c-mpl responsible for familial essential thrombocythemia
2004 - 2006 Molecular-based study for the development of monoclonal antibody therapy in chemokine receptors, CCR4 and CXCR3
2001 - 2003 多発性骨髄腫における染色体転座の発症機構と腫瘍化への関与
2000 - 2003 Development of the optimal therapies based on molecular genetics of multiple myeloma
1999 - 2001 Clinical and biological analysis of familial essential thrombocythemia
1999 - 2000 形質細胞性腫瘍の発生に関与する癌遺伝子の単離同定とその機能解析
難治性リンパ系腫瘍におけるヒストン脱アセチル化酵素阻害剤に対する耐性化機構の解明
リンパ系腫瘍におけるMUM1/IRF4の転写標的遺伝子の同定と治療標的分子の探索
Show all
Papers (176):
Yuma Sakamoto, Takashi Ishida, Ayako Masaki, Takayuki Murase, Eiichi Ohtsuka, Morishige Takeshita, Reiji Muto, Ilseung Choi, Hiromi Iwasaki, Asahi Ito, et al. Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma. International journal of hematology. 2024
Naohiro Matsunaga, Tomotaka Suzuki, Nozomi Nishitarumizu, Yoko Nakanishi, Aki Kondo, Yukiyasu Kato, Toru Ebina, Yoshiaki Marumo, Tomoyuki Nakamura, Takahiro Nakashima, et al. Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution. Clinical lymphoma, myeloma & leukemia. 2024. 24. 8. 531-536
Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, et al. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305). Cancer Science. 2024
Takuto Tachita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Ayako Masaki, et al. Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone. Cancer Medicine. 2024
Takahiro Nakashima, Shigeru Kusumoto, Takashi Ishida, Chie Kato, Shinya Hagiwara, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Hirokazu Komatsu, et al. Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapy. Hepatology Research. 2024
Ken Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, Gakuto Ogawa, Tomonori Mizutani, Nobuhiko Yamauchi, Noriko Fukuhara, Toshiki Uchida, Kazuhito Yamamoto, Kana Miyazaki, et al. Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601. BLOOD. 2018. 132
1991~1994 Visiting scientist, Aichi Cancer Center Research Institute, Nagoya, Japan1994~1997 Visiting scientist/Postdoctoral fellow, Department of Pathology, Columbia University, New York, NY, USA
Association Membership(s) (8):
European Hematology Association
, American Society of Hematology
, 日本臨床腫瘍学会
, 日本造血細胞移植学会
, 日本癌学会
, 日本血液学会
, 日本内科学会
, Japanese Society of Myeloma